Experiences of returning
Director York Trials Unit
University of York
BioMed Central Colloquium
Thursday 8th February 2007, The Royal College of Physicians, London, UK
Why do I publish with open
• Easily accessible by others
• Retention of copyright (means copies can
be held on your own website).
Why not more?
• Perceived poor academic impact for some
open access journals.
» Important when joint authors are junior academics
and need to ‘beef’ up their CVs.
» My University will no longer subscribe to an
open publisher. Consequently the cost deters
me from publishing more.
First BMC paper - speed
• Torgerson DJ, Bell-Syer SEM. Hormone
replacement therapy and prevention of
vertebral fractures: a meta-analysis of
randomised trials. BMC Musculoskeletal
Disorders 2001, 2:7.
» Total Downloads since publication approx
Last BMC paper
• Petherick ES, O'Meara S, Spilsbury K,
Iglesias CP, Nelson EA, Torgerson DJ.
Patient acceptability of larval therapy for
leg ulcer treatment: a randomised survey
to inform the sample size calculation of a
randomised trial. BMC Medical Research
Methodology 2006, 6:43.
» Downloads 1318
• Must improve academic impact and
• Cost – perhaps liaise with funding bodies
so that papers/protocols associated with a
grant from a funding body is offered free
• My experiences with open publishing have
• I recommend it to colleagues.
• Some reluctance due to lower impact
factors than some ordinary journals.
• Cost can be a deterrent.